Aethlon medical announces second quarter financial results and provides corporate update

San diego , nov. 14, 2022 /prnewswire/ -- aethlon medical, inc. (nasdaq: aemd), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today reported financial results for its second quarter ended september 30, 2022 and provided an update on recent developments.  company updates aethlon medical is continuing the research and clinical development of its hemopurifier®, a therapeutic blood filtration system that can bind and remove harmful exosomes and life-threatening viruses from blood.
AEMD Ratings Summary
AEMD Quant Ranking